Our Friday research round-up – abstracts you may not have already seen here

August 19, 2011


Friday research roundup – abstracts from some recently published papers not already highlighted on the MEA website:

1 Antibody responses against xenotropic murine leukemia virus-related virus envelope in a murine model.

www.ncbi.nlm.nih.gov/pubmed/21494670

2 Shoenfeld's syndrome after pandemic influenza A/H1N1 vaccination.

www.ncbi.nlm.nih.gov/pubmed/21483283

Dr Charles Shepherd note: This syndrome should form part of the differential diagnosis of ME/CFS where patients also complain of arthritic/joint symptoms – especially following a vaccination.

3 Therapist effects in routine psychotherapy practice: an account from chronic fatigue syndrome.

www.ncbi.nlm.nih.gov/pubmed/21271461

4 Amisulpride vs. fluoxetine treatment of chronic fatigue syndrome: a pilot study.

www.ncbi.nlm.nih.gov/pubmed/21112746

5 Heterologous immunity: Immunopathology, autoimmunity and protection during viral infections

informahealthcare.com/doi/abs/10.3109/08916934.2011.523277

Dr Charles Shepherd note: Includes reference to how an inappropriate immune response can lead to a cascade of events leading to immunopathology in conditions such as MS, SLE, sarcoidosis and ME/CFS.

3 thoughts on “Our Friday research round-up – abstracts you may not have already seen here”

  1. If anyone is interested, when monkeys have been artificially inoculated with human gammaretroviruses the virus rapidly clears from the blood and then moves into certain organs. It is here where you would expect to find more diversity. This is no different than with other mouse viruses.

    But it should be taken into consideration that monkeys and mice are no substitute for what will occur in the human body. That will only be understood with further research. Scientists are already reporting that in very sick patients there is no immune response until those patients have been taking anti-retrovirals for a while.

  2. Dr Charles Shepherd

    Additional note re abstract 4:

    Amisulpride is an atypical antipsychotic drug that is normally used to treat people with schizophrenia.

    I suspect that we do not have any instances here in the UK where this drug has been used to treat ME/CFS.

    If it has, I would be interested to know the outcome.

    CS

Comments are closed.

Shopping Basket